Dermfix apžvalga: nuo medicininės fototerapijos iki pažangių raudonosios šviesos panelių

Dermfix is a relatively new name in the red light panel market, but the brand has a much longer history of phototherapy experience behind it. Dermfix Limited has been in business since 2009, and the company's managers and key specialists have been working in the field of light therapy and medical devices for over two decades. Dermfix's history is primarily associated with medical narrowband UVB phototherapy, and in 2025 this experience was transferred to the new RLF series of red and near-infrared light panels.

It is this historical fact that is the most important distinction of Dermfix in the European red light therapy market.. Dermfix entered the market with more than two decades of experience in the field of light therapy and medical device manufacturing, and of course this is reflected in their production technologies. In the new RLF red and near infrared light panel series This is visible not only in the technical characteristics, but also in the approach to measurement transparency, safety requirements, product documentation and European warranty service.

What is Dermfix?

Dermfix is a European manufacturer of phototherapy products operating through Dermfix Group, which includes Dermfix Ltd, Dermfix GmbH and Dermfix Inc. The group's specialists have been working in the field of light therapy and medical devices for more than 20 years.

An important part of this story is that Dermfix UVB devices are certified class IIa medical devices, and Dermfix Ltd designs and manufactures medical devices according to ISO 13485 quality management system and MDSAP (Medical Device Single Audit Program) requirements.

This is an important fact when evaluating this brand of red light therapy devices, because ISO 13485 is not just a general quality certificate - it is a standard focused specifically on the design and production of medical devices. It should be emphasized that a significant number of common consumer LED therapy brands do not have such experience as Dermfix and the associated advantages.

However, it is important to clearly distinguish between two product categories. Dermfix UVB phototherapy devices are Class IIa medical devices, while RLF red and near-infrared light panels are consumer products, not medical devices. Many years of experience in developing medical phototherapy equipment are important in this case not as an argument for the medical status of RLF panels, but as a basis for the manufacturer's approach to measurements, safety, documentation, and presentation of technical data.

From medical UVB phototherapy to red light

In 2025, Dermfix entered the rapidly growing segment of red and near-infrared light therapy with RLF panel series.

This is a fairly logical evolution for the brand. The company already had experience in developing light-based devices, working with optical radiation safety requirements and the European regulatory environment. In the RLF series, this experience was applied not to UVB phototherapy, but to red and near-infrared light systems for home and professional use.

The result is panels that are focused not only on high power, but also on fairly extensive parameter control capabilities.

7 wavelengths – one of the most striking features of the RLF series

Dermfix RLF panels contain seven selectable wavelengths: 480, 630, 660, 810, 830, 850 and 1060 nm. Most of them fall into the classic red and near-infrared light range:

630 and 660 nm – red light;
810, 830, 850 and 1060 nm – near infrared light;
480 nm – additional blue light channel.

Among them 660nm and 850nm are two wavelengths widely used in red light therapy devices, but Dermfix does not limit itself to this classic combination and includes in its panels includes 480 nm – additional blue light spectrum. In higher-end Dermfix RLF models, the intensity of each wavelength can also be adjusted adjustable individually from 0 to 100 %, so the user is not tied to a single factory-set ratio of red to NIR light.

Greater focus on actual measurements rather than declared power

One of the most problematic areas in the red light panel market is the presentation of irradiance, or light power density. The mW/cm² figure alone does not always allow for an objective comparison of different panels – it is important to know and what measuring device was used to obtain the result, and at what distance from the panel was the measurement taken.

This is especially important because different measuring devices can evaluate LED light very differently. A broadband solar meter can show approximately twice the result of a spectrometer for LED light. As a result, for example, 200 mW/cm² from one manufacturer and 90 mW/cm² from another manufacturer do not necessarily mean that the first panel is more than twice as powerful - in some cases, these numbers may describe very similar actual light intensity, just measured with different devices.

Therefore, if the manufacturer does not specify measuring instrument and distance, it is not possible to reliably compare panels based on the declared irradiance number alone. This is where the connection with Dermfix's long-standing experience in developing phototherapy equipment is visible. The manufacturer not only provides the irradiance number of RLF panels, but also indicates measurement method and distance. The results of the RLF models are presented based on spectrometer measurements.

The largest Dermfix RLF6000 The model's stated result is 92 mW/cm² at 15 cm distance, measured with a spectrometer.

CE compliance and EN 60335-2-27

Another advantage of the RLF series that Dermfix emphasizes is documented safety compliance. Dermfix states that the RLF panels have CE compliance, including EN 60335-2-27, which applies to electrical devices that expose human skin to optical radiation. This is especially relevant for red and near-infrared light equipment, because here we are not just talking about a simple household LED lamp, but about a high-power light source used close to the human body.

This standard should not be confused with medical device certification. The RLF series panels are not the same as Dermfix medical UVB phototherapy devices. However, the manufacturer's optical and electrical safety compliance documentation is one of the arguments that sets the RLF series apart in the crowded consumer LED panel market.

RLF6000 – the current flagship of the series

Dermfix's approach to red light therapy is best reflected in RLF6000 – the largest panel of the entire body. It uses:

1200 × 5W dual-chip LED;
7 wavelengths – 480, 630, 660, 810, 830, 850 and 1060 nm;
individual for each channel 0-100 % adjustment;
92 mW/cm² at 15 cm intensity measured by a spectrometer;
30° beam angle;
adjustable NIR pulsation;
11 ready-made modes;
possibility of saving 3 individual programs;
touch screen and remote control.

The 180 x 60 cm RLF6000 is a true full-body format, aimed at both demanding home users and studios or other professional spaces. It is also a model that shows where Dermfix is trying to compete with the premium market leaders: not only in the number of LEDs, but also extensive individual control and a wealth of technical functions.

European logistics – no less important than technical parameters

Large red light panels can weigh several tens of kilograms, so when buying in Europe, it is important to consider not only the specifications, but also what will happen if a problem occurs. Dermfix GmbH is based in Austria, and the goods are supplied to European Union customers from EU warehouses. This means that EU buyers do not need to pay additional import duties, and delivery and possible returns take place within Europe.

The manufacturer states that delivery and return usually take about 2–5 business days, depending on the country and the specific situation.

RLF panels are provided 3 year warranty.

What makes Dermfix stand out from other red light panel manufacturers?

The greatest uniqueness of Dermfix, in our opinion, is not one specific technical parameter. It is a combination of the manufacturer's origin and a new technological direction.

The red light panel series is new, but it is backed by a company with over two decades of experience in developing phototherapy equipment, including certified Class IIa medical devices. RLF panels themselves are not medical devices, but this previous experience is reflected in the manufacturer's approach to presenting technical data - for example, irradiance results are indicated together with the measuring instrument and distance. To this, Dermfix adds seven adjustable light channels, EN 60335-2-27 safety compliance and European logistics.

This creates a fairly clear positioning for the Dermfix brand: technologically advanced premium-class panels, backed not only by LED product marketing, but also by previous experience in the field of professional phototherapy equipment.

Why do Dermfix panels seem like the most rational choice?

Dermfix is primarily worth considering for users who are interested not only in the principle of red light itself, but also in the ability to control the device quite precisely. The Dermfix RLF panel series is especially interesting if:

Do you want wider than the standard 660/850 nm spectrum;
Individual adjustment of wavelengths and intensity is important;
Looking for a lady with clearly presented irradiance measurements;
You are evaluating documented safety compliance;
You want to buy from a European company with an EU warehouse and local warranty service;
looking for a large full body panel for home or professional space.

Meanwhile, for a user who only needs a simple 660/850 nm panel for a few body areas, some of the RLF features may be redundant. The seven channels, pulsation settings, and individual programs are of greatest value when they are actually planned for use.

Dermfix advantages and disadvantages in brief

Main advantages:

More than 20 years of experience in the field of phototherapy and medical devices;
Experience in medical device manufacturing according to ISO 13485 and MDSAP systems;
7 selectable wavelengths in RLF panels;
Individually adjustable light channels;
Irradiance is measured and publicly reported by a spectrometer;
CE compliance, including EN 60335-2-27;
Wide selection from smaller to full body panels;
3 year warranty;
EU warehouses and European service.

What is worth considering:

The RLF red light panel series is still relatively new on the market;
RLF panels should not be confused with the company's medical UVB phototherapy devices;
the most advanced models may have more features than the average user needs;

Verdict

Dermfix is an interesting brand in the European red light therapy market: a new player in a product category, but with a much older history in phototherapy.

This is what is today one of the strongest Dermfix The RLF series doesn't seem like a random attempt to capitalize on the growing popularity of red light therapy - it's a natural development direction for a manufacturer that has been working with light therapy and medical devices for more than two decades.

Seven adjustable wavelengths, spectrometer provides irradiance results, EN 60335-2-27 safety compliance, 3-year warranty and EU logistics gives Dermfix a fairly clear place in the premium brown light therapy market segment.

The biggest question now is not whether Dermfix can technically compete with the best European red light panels – RLF6000 can. What will be more important is how quickly the relatively new RLF series will build the same market reputation and consumer trust that premium brands operating in this segment for a longer period of time already have.

Our verdict – if the priority is technical capabilities, transparent measurements, documented safety compliance and European service, Dermfix is currently one of the strongest red light therapy manufacturers worth paying attention to.